SARS-CoV-2 Antibodies, Nucleocapsid (N Ab) are produced by the immune system in response to the nucleocapsid protein of the SARS-CoV-2 virus. This protein is found inside the virus and is not targeted by most COVID-19 vaccines, which focus on the spike (S) protein. As a result, nucleocapsid antibody testing is commonly used to distinguish natural infection from vaccine-induced immunity.
After infection, the body generates antibodies against multiple viral components, including the nucleocapsid protein. These antibodies can typically be detected within 1–3 weeks after infection and may persist for months, although levels can decline over time.
This test is especially helpful in:
- Identifying prior COVID-19 infection
- Understanding population-level exposure (seroprevalence)
- Differentiating infection from vaccination response
However, it’s important to note that antibody testing should not be used alone to diagnose an active infection. Molecular tests (like PCR) or antigen tests are required for detecting current infection.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.